Medicaid Reimbursement Landscape Analysis
Conducted a 50-state assessment of Medicaid programs to identify the Medicaid and newborn screening landscape for a gene therapy, and subsequently developed a strategy for 25 states to secure Medicaid coverage and reimbursement and newborn screening. For a different client, developed newborn screening legislation for a new therapeutic area.